Matches in Wikidata for { <http://www.wikidata.org/entity/Q71165185> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q71165185 description "article scientifique publié en 1980" @default.
- Q71165185 description "artículu científicu espublizáu en febreru de 1980" @default.
- Q71165185 description "im Februar 1980 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71165185 description "scientific article published on 01 February 1980" @default.
- Q71165185 description "wetenschappelijk artikel" @default.
- Q71165185 description "наукова стаття, опублікована в лютому 1980" @default.
- Q71165185 name "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 name "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 name "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 type Item @default.
- Q71165185 label "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 label "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 label "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 prefLabel "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 prefLabel "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 prefLabel "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 P1433 Q71165185-AABA1686-CF94-42F2-ACDF-7BC82FD04C4C @default.
- Q71165185 P1476 Q71165185-2A35311A-1BDE-4366-B575-9573FEFD2593 @default.
- Q71165185 P2093 Q71165185-069E5EF6-BD82-4206-B6D0-2B84D4C54DB5 @default.
- Q71165185 P2093 Q71165185-1AFE6052-2671-4B61-BD13-769B5D591CC1 @default.
- Q71165185 P2093 Q71165185-EEAB1C6D-6A3F-4EE9-8C9A-EDBC5C8CE901 @default.
- Q71165185 P304 Q71165185-88A5BEAB-ACE5-4CA1-AB86-C01DC7A35C9A @default.
- Q71165185 P31 Q71165185-9493AFC5-158A-4199-B520-903B05BE89D8 @default.
- Q71165185 P356 Q71165185-2AC26A82-7B51-44E4-A9D8-2EE464BD9F59 @default.
- Q71165185 P407 Q71165185-01AA5E52-E3E1-45E7-9B07-E8715544CCE0 @default.
- Q71165185 P433 Q71165185-32CEA6F9-9F4D-4024-82DA-994D43419E32 @default.
- Q71165185 P478 Q71165185-A319CE41-E64B-4F04-830B-7DC3CFDB1434 @default.
- Q71165185 P577 Q71165185-4328FCFF-8F56-4226-BFC1-F062987A0A35 @default.
- Q71165185 P698 Q71165185-BA55D06A-EB6B-4CDF-AE71-3333406C299B @default.
- Q71165185 P921 Q71165185-51501E16-20AC-47EA-A78E-41A3540B8035 @default.
- Q71165185 P356 0024-3205(80)90317-3 @default.
- Q71165185 P698 7366335 @default.
- Q71165185 P1433 Q5256275 @default.
- Q71165185 P1476 "Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels" @default.
- Q71165185 P2093 "A J Friedhoff" @default.
- Q71165185 P2093 "E Friedman" @default.
- Q71165185 P2093 "E Meller" @default.
- Q71165185 P304 "541-547" @default.
- Q71165185 P31 Q13442814 @default.
- Q71165185 P356 "10.1016/0024-3205(80)90317-3" @default.
- Q71165185 P407 Q1860 @default.
- Q71165185 P433 "7" @default.
- Q71165185 P478 "26" @default.
- Q71165185 P577 "1980-02-01T00:00:00Z" @default.
- Q71165185 P698 "7366335" @default.
- Q71165185 P921 Q251347 @default.